Clinical studies have shown that semaglutide can lead to significant weight loss in people with obesity or overweight. In a 68-week study, participants who took semaglutide lost an average of 15% of their body weight, compared to 2.4% for those who took a placebo.
Clinical studies have shown that semaglutide can lead to significant weight loss in people with obesity or overweight. In a 68-week study, participants who took semaglutide lost an average of 15% of their body weight, compared to 2.4% for those who took a placebo.